
AI/ML Systems, preparing an FDA submission Part II: ‘Pre-sub strategy’
Summary In Part II of this series, Leon shifts the focus from initial regulatory positioning to one of the most underestimated and often misused steps

Summary In Part II of this series, Leon shifts the focus from initial regulatory positioning to one of the most underestimated and often misused steps

Summary FDA submissions for AI/ML-enabled medical devices rarely fail because of a single mistake – they unravel due to a series of early assumptions that

At MedQAIR, we work with professionals who understand that regulatory and quality activities need to be embedded throughout the product lifecycle, from early concept decisions

At MedQAIR, our work sits at the intersection of regulatory expertise, quality systems, and digital innovation. Supporting manufacturers of Software as a Medical Device (SaMD),

In January 2024, the FDA issued a landmark Quality Management System Regulation (QMSR) final rule that overhauls 21 CFR Part 820 to incorporate ISO 13485:2016

Introduction Medical device companies today face a complex web of regulations when marketing products globally. Unique Device Identification (UDI) systems have been adopted worldwide to

At MedQAIR, we’re proud of the people who make our mission possible. Each team member brings a unique blend of experience, perspective, and commitment to

At MedQAIR, we combine regulatory expertise with a passion for building bridges, connecting continents, linking innovators with compliance, and uniting people who share deep industry

Navigating post-market compliance under MDR/IVDR has never been more complex. As regulatory demands rise, responsibility no longer rests solely with the manufacturer, it extends across
Cookies help us improve your experience on our website. By using our site, you consent to the use of cookies as described in this policy.